UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

September 2, 2011
(Date of earliest event reported)

000-23016
(Commission File Number)

Medifast, Inc.
(Exact name of registrant as specified in its charter)

Delaware
  
13-3714405
(State of Incorporation)
  
(IRS Employer Identification No.)
     
11445 Cronhill Drive
    
Owings Mills, Maryland
  
21117
(Address of principal executive offices)
  
(Zip Code)

Registrant's telephone number, including area code:   (410) 581-8042

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

Item 5.07 
Submission of Matters to a Vote of Security Holders.

The Medifast, Inc.  Annual Meeting of Shareholders duly noted, with a requisite voting  quorum  was held on September 2, 2011 at the Sunset Island Clubhouse, located at 1 Beach Side Drive, Ocean City, MD  21842.  The following matters were voted upon at the Annual Meeting, with the results indicated:

1a.
Election of Class II Directors
 
Director 
  
Votes For
    
Votes
Against
    
Abstentions
    
Broker Non-
Votes
  
Harvey C. Barnum*
   9,193,628     137,715     4,705     3,156,807  
Michael C. MacDonald
   9,186,313     144,830     4,884     3,156,807  
Jerry D. Reece*
   9,113,925     217,418     4,684     3,156,807  
 
* Independent Director; independence in accordance and as determined by the rules of the New York Stock Exchange. After the election, the Company has ten independent directors and four non-independent directors.
 
1b.
Election of Management Directors
 
Director 
  
Votes For
    
Votes
Against
    
Abstentions
    
Broker Non-
Votes
  
Michael S. McDevitt
   9,191,334     140,239     4,475     3,156,807  
Margaret E. Sheetz
   9,174,612     156,531     4,905     3,156,807  

2.
Proposal to ratify the appointment of McGladrey & Pullen, LLC, as the Company’s independent auditors for the year ending December 31, 2011.
 
Votes For
  
Votes Against
    
Abstentions
  
12,368,971
   95,039     28,845  

3.
Proposal to approve the non-binding advisory vote on the Company’s Executive Compensation.
 
Votes For
  
Votes Against
    
Abstentions
    
Broker Non-
Votes
  
9,052,558
   229,258     54,232     3,156,807  

4.
Proposal to approve the non-binding advisory vote frequency of advisory votes on the Company’s Executive Compensation.
 
Three Years
  
Two Years
    
One Year
    
Abstentions
  
4,855,557
   30,459     4,396,668     53,364  
 
 
2
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
MEDIFAST, INC.
  
     
Dated: September 7, 2011
    
     
 
/s/ Brendan N. Connors
  
 
Brendan N. Connors
  
 
Chief Financial Officer
  
 
 
3